Ewha Womans University
Seoul, 03760, South Korea
NCT Number: NCT06426342
The goal of this feasibility study is to develop a new metaverse-based blended online intervention using an online program and coaching via metaverse to prevent depression among Generation MZ Employees in South Korea. In addition, this study primarily explores reach and acceptability and secondarily evaluates the preliminary effectiveness of this preventive intervention on Korea's Gen MZ Employees.
Looking for future studies?
Notify Me20 year–42 year
All sexes
Interventional
Not applicable
Seoul, 03760, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A new metaverse-based blended online intervention was developed using an online program and coaching via metaverse to prevent depression among Generation MZ Employees in South Korea.
Time frame: baseline
Recruitment will be assessed by the number of potentially eligible participants enrolled.
Time frame: Baseline, at 5 weeks after intervention.
The retention rate will be calculated as the percentage of completion rates for the entire intervention and questionnaires until the completion of a 5 weeks after intervention.
Time frame: at 5 weeks after intervention.
Acceptability refers to how participants perceive and feel about the intervention and its components. A 13- item questionnaire was developed based on the Client Satisfaction Questionnaire to measure acceptability with three subcategories: helpfulness (three items), suitability (seven items), and satisfaction (three items). Participants responded on a 5- point Likert scale ranging from 1 (not at all) to 5 (very).
Time frame: Baseline, at 5 weeks after intervention.
The Center for Epidemiological Studies Depression Scale with 20- item will be used to measure depressive symptoms using a 4- point Likert scale. The total score ranges from 0 to 60, with higher scores indicating higher levels of depressive symptoms.
Time frame: Baseline, at 5 weeks after intervention.
Positive and Negative Affect Schedule will used to measure positive and negative affect using a 5- point Likert scale. The total score ranges from 10 to 50, with higher scores indicating a greater perception of positive affect or negative affect.
Time frame: Baseline, at 5 weeks after intervention.
the Satisfaction with Life Scale with 5- items will be used to assess life satisfaction using a 7- point Likert scale. The total score ranges from 5 to 35, with higher scores indicating greater life satisfaction.
Time frame: Baseline, at 5 weeks after intervention.
Pittsburgh Sleep Quality Index with 19 items will be used to evaluate overall sleep quality. 19 self-reported items includes seven subcategories: subjective sleep quality, sleep latency, sleep duration, habitual sleep effi ciency, sleep disturbances, use of sleeping medication, and daytime dysfunction.
The total score ranges from 0 to 21, with higher scores indicating worse sleep quality.
Time frame: Baseline, at 5 weeks after intervention.
Burnout assessment tool with 23 items will be used to measure burnout including four core burnout symptoms: Exhaustion, Mental Distance, Emotional Impairment, and Cognitive Impairment.
For each core scale, the average score is calculated by summing the scores of the items in that scale and dividing by the number of items in that scale.
Score Interpretation:
1.0 to 1.9: Very low or no burnout symptoms. 2.0 to 2.9: Mild burnout symptoms. 3.0 to 3.9: Moderate burnout symptoms. 4.0 to 5.0: Severe burnout symptoms
Ewha Womans University
Other
Development and Feasibility of a Metaverse-based Blended Online Intervention to Prevent Employees' Depression: Applying Intervention Mapping
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06829953
Anhedonia, Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT02274688
Alcohol and Drug Use, Behavior
Seattle, Washington, United States
View Trial DetailsNCT07475039
Behavior, Behavioral Symptoms
Gainesville, Florida, United States
View Trial DetailsNCT06980441
Anxiety, Anxiety Disorders
Kabul, Afghanistan
View Trial Details